Ledger.Open graph →
SEC Form D · filed November 29, 2013

OXYGEN BIOTHERAPEUTICS, INC

Offering
$6.6M
Sold
$6.6M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
MORRISVILLE, NC
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (14)

William A. Chatfield · Morrisville, NCDirectorVincenzo Cortese · San Jose, CADirectorJeffrey M. Feuereisen · Southfield, MIDirectorAndrew M. Feuereisen · Southfield, MIDirectorCharitharth V. Lal · Vestavia Hills, ALExecMarc Porosoff · Stamford, CTDirectorJohn Kelley · Boulder, COExecBrett Topche · Philadelphia, PAExecErnest Mast · Vancouver, British Columbia, CanadaDirectorGlenn Kennedy · New York, NYDirectorGeorgia Prinsloo · New York, NYDirectorMichael Mayer · New York, NYDirectorMark Gilligan · London, United KingdomDirectorJohn Kelley · Boston, MAExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗